Atenolol
- Product NDC
- 53002-1138
- 11-digit product format
- 530021138
- Labeler code
- 53002
- Product ID
- 53002-1138_2507724a-897f-4cab-bd08-0576e8743e46
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Atenolol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA074056
- Marketing category
- ANDA
- Marketing start
- 1995-02-17
- Marketing end
- 0000-00-00
- Substance
- ATENOLOL
- Active strength
- 100 mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 53002-1138-0 | Atenolol | 100 in 1 BOTTLE | TABLET | 100 | | 11 |
| 53002-1138-3 | Atenolol | 30 in 1 BOTTLE | TABLET | 30 | | 11 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53002-1138 | ATENOLOL TABLET [RPK PHARMACEUTICALS, INC.] | 11 | Legacy NDC, 2 package rows | 20230609_616bf08d-5adf-4d10-9a2e-bcb536b7c2e0.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53002-1138-0 | 53002113800 | 100 TABLET in 1 BOTTLE (53002-1138-0) | 100 tablet | 2018-10-01 | 0000-00-00 | No | No | Current |
| 53002-1138-3 | 53002113803 | 30 TABLET in 1 BOTTLE (53002-1138-3) | 30 tablet | 2018-10-01 | 0000-00-00 | No | No | Current |